Delivery Order SPE2DB22D3016-SPE2DB24FAUK5

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical with a firm fixed price of $1,707.85 and a completion date of March 1, 2024. The contract is for the supply of RECTIV 0.4% ointment in 30 gram packages. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,062.14 firm fixed-price delivery order is for the supply of 4566134271 - RECTIV 0.4% OINTMENT 30GM, with a completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $3,807.46 for the delivery of 0.4% Rectiv ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 8, 2024, with a firm fixed-price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,506.07 Firm Fixed Price delivery order contract is for the provision of RECTIV 0.4% ointment, a medical product, with a period of performance through February 12, 2025. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,137.00, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of a pharmaceutical product, "RECTIV 0.4% OINTMENT 30GM," with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564885184 RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $1,958.04 and an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, RECTIV 0.4% Ointment 30GM. The $3,705.96 contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This federal contract award SPE2DB20D1047|SPE2DB25FF32V, valued at $2,386.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product, with a completion date of December 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $6,036.56 and has an ultimate completion date of November 25, 2024. The contract is for the procurement of RECTIV 0.4% OINTMENT 30GM, a medical product. This award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,467.80 firm fixed-price delivery order is for the supply of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAUK5
    Delivery Order

This federal contract award is for the delivery of pharmaceutical products, specifically 0.4% RECTIV ointment in 30 gram tubes, to the Defense Logistics Agency (DLA). The $2,158.71 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 6, 2024 and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a broad range of pharmaceutical products and medical supplies to support government medical institutions and beneficiaries.

Generated 5/16/25, 12:07 PM